搜索临床试验以:Autologous stem cell transplant
总计66537个结果
-
Nanfang Hospital, Southern Medical UniversityZhujiang Hospital完全的急性髓性白血病 | 风险分层
-
Memorial Sloan Kettering Cancer CenterBeyondSpring Pharmaceuticals Inc.主动,不招人
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); California Institute for Regenerative Medicine (CIRM)主动,不招人爱滋病毒感染 | 浆母细胞淋巴瘤 | 复发性成人霍奇金淋巴瘤 | 复发性成人非霍奇金淋巴瘤 | III 期套细胞淋巴瘤 | IV 期套细胞淋巴瘤 | 复发性伯基特淋巴瘤 | 成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 复发性滤泡性淋巴瘤 | III 期滤泡性淋巴瘤 | IV 期滤泡性淋巴瘤美国
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research Consortium主动,不招人
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester; University of... 和其他合作者主动,不招人弥漫性大 B 细胞淋巴瘤 (DLBCL) | 复发性弥漫性大 B 细胞淋巴瘤 (DLBCL) | 难治性弥漫性大 B 细胞淋巴瘤 (DLBCL)美国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Fondazione EMN Italy Onlus主动,不招人
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; State University of New York - Upstate Medical... 和其他合作者主动,不招人
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee Moffitt Cancer Center...主动,不招人
-
University of Maryland, BaltimoreGilead Sciences; University of Miami Sylvester Comprehensive Cancer Center主动,不招人滤泡性淋巴瘤 | B细胞淋巴瘤 | 华氏巨球蛋白血症 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | 非霍奇金淋巴瘤 | 小淋巴细胞淋巴瘤 | 转化淋巴瘤 | 惰性淋巴瘤美国
-
Beth Israel Deaconess Medical CenterMassachusetts General Hospital; Rambam Health Care Campus; Dana-Farber Cancer Institute; Brigham...完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Medical Research Council完全的
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese Tumortherapie主动,不招人
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire完全的
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbH主动,不招人
-
Barts & The London NHS Trust终止
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)完全的
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Otsuka America Pharmaceutical完全的
-
National Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteEntrinsic Health完全的
-
Masonic Cancer Center, University of Minnesota主动,不招人
-
Celularity Incorporated主动,不招人心血管疾病 | 血管疾病 | 肿瘤 | 免疫系统疾病 | 组织学类型的肿瘤 | 淋巴增生性疾病 | 免疫增生性疾病 | 血液病 | 出血性疾病 | 多发性骨髓瘤 | 副蛋白血症 | 血液蛋白失调 | 抗肿瘤药 | 药物的生理作用 | 镇痛药,非麻醉药 | 周围神经系统药物 | 止血障碍 | 止痛药 | 感觉系统代理 | 肿瘤,浆细胞美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的套细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性惰性成人非霍奇金淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 复发性惰性成人非霍奇金淋巴瘤美国
-
Fred Hutchinson Cancer CenterADC Therapeutics撤销复发性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤,未另行说明 | 具有 MYC 和 BCL2 或 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤 | 难治性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤美国
-
The Lymphoma Academic Research Organisation完全的
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者终止
-
Celgene完全的
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline; NYU Langone Health 和其他合作者完全的
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research Foundation终止
-
Cedars-Sinai Medical Center完全的
-
St. Jude Children's Research HospitalAssociation of Pediatric Hematology Oncology Nurses完全的
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization, Inc.; Princess Margaret...完全的
-
PETHEMA FoundationCelgene Corporation; Amgen主动,不招人
-
Universitätsklinikum Hamburg-Eppendorf完全的